NovaBay Pharmaceuticals Inc. (NBY) revealed Loss for second quarter that decreased from last year
The company's bottom line totaled -$1.6 million, or -$1.37 per share. This compares with -$4 million, or -$44.43 per share, in last year's second quarter.
The company's revenue for the quarter fell 31.4% to $2.4 million from $3.5 million last year.
NovaBay Pharmaceuticals Inc. earnings at a glance (GAAP) :
-Earnings (Q2): -$1.6 Mln. vs. -$4 Mln. last year.
-EPS (Q2): -$1.37 vs. -$44.43 last year.
-Revenue (Q2): $2.4 Mln vs. $3.5 Mln last year.
For comments and feedback: editorial@rttnews.com